← Latest papers
📄 medicine

Effect of Adding a Low Dose Epinephrine Bolus Prior to Epinephrine Infusion on Maternal Hemodynamic Stability During Cesarean Section Under Spinal Anesthesia: A Randomized Clinical Trial

This randomized clinical trial demonstrates that administering a low-dose epinephrine bolus prior to epinephrine infusion significantly reduces the incidence of maternal hypotension and rescue vasopressor requirements during cesarean delivery under spinal anesthesia without adversely affecting neonatal outcomes.

Original authors: Dina Turki, Asmaa Adel, Khaled Abdelfattah Sarhan, Nashwa Elzayat, Ahmed Elsakka, AbdElKhalik Mahmoud Shaban

Published 2026-10-05
📖 4 min read☕ Coffee break read

Original authors: Dina Turki, Asmaa Adel, Khaled Abdelfattah Sarhan, Nashwa Elzayat, Ahmed Elsakka, AbdElKhalik Mahmoud Shaban

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Every year, thousands of women undergo cesarean sections, a major surgery that often relies on spinal anesthesia to keep them comfortable and still. This technique involves injecting medication into the fluid surrounding the spinal cord to block pain signals. While highly effective, this block has an unintended side effect: it temporarily shuts down the nerves that help keep blood vessels tight. Without that natural squeeze, blood pools in the legs and abdomen, causing a sudden drop in blood pressure. This condition, known as hypotension, is the most common complication of the procedure. It can make the mother feel dizzy or nauseous and, more critically, can reduce the flow of oxygen-rich blood to the baby. For decades, doctors have fought this drop by giving drugs that act like a chemical squeeze, forcing blood vessels to tighten again. The goal is simple but vital: keep the mother's blood pressure steady so both she and her baby remain safe.

Recently, a team of researchers at Cairo University turned their attention to a specific strategy for managing this blood pressure drop. They were investigating the use of epinephrine, a drug that naturally occurs in the body and helps regulate heart rate and blood vessel width. While doctors had already found that slowly dripping epinephrine into a patient's vein could help prevent low blood pressure, they wondered if the timing of the delivery mattered. The standard approach involves starting the drip immediately after the spinal injection, but there is a brief window where the drug takes time to build up in the system while the spinal block is already working its way down. The researchers hypothesized that giving a tiny, quick dose of the drug right at the start—a "bolus"—before the slow drip began might bridge that gap. They wanted to see if this head start would keep blood pressure more stable than the drip alone.

To test this idea, the team recruited eighty healthy women scheduled for elective cesarean sections. They were divided into two groups. One group received a small, four-microgram dose of epinephrine injected into their vein the moment the spinal anesthesia was finished, followed immediately by the standard continuous drip. The other group received a harmless saline injection instead of the drug, followed by the exact same epinephrine drip. Throughout the surgery, the medical team closely watched the mothers' heart rates and blood pressure, recording the numbers every few minutes. They defined a significant drop in blood pressure as a decrease of more than twenty percent from the woman's normal level, a threshold that would usually require extra medication to fix.

The results showed a clear difference between the two groups. In the group that received the initial small dose, only four women experienced a significant drop in blood pressure. In contrast, twelve women in the group that received only the drip had to be treated for low blood pressure. This means that the strategy of adding the quick shot at the beginning reduced the likelihood of a blood pressure crash by a noticeable margin. Furthermore, the women who got the initial dose needed far fewer rescue doses of a different drug, norepinephrine, to fix their blood pressure if it did dip. The researchers found that the mothers in the bolus group maintained slightly higher blood pressure and a more stable heart rate during the critical first minutes of the surgery.

Importantly, the study confirmed that this extra step did not cause new problems. The researchers were concerned that adding more epinephrine might cause the heart to race too fast or blood pressure to spike too high, but they found no significant increase in these side effects. The women in the bolus group also reported feeling less nauseous, a symptom often linked to low blood pressure. Perhaps most reassuringly, the babies were unaffected by the change in the mother's treatment plan. The researchers checked the babies' health immediately after birth using standard scoring systems and by testing the blood from the umbilical cord. The results were identical for both groups, showing that the extra drug did not harm the newborns.

This study suggests that the timing of a medication can be just as important as the medication itself. By giving a tiny, immediate dose of epinephrine before the continuous drip takes over, doctors can provide a smoother transition for the mother's body as it adjusts to the spinal anesthesia. It is a small adjustment to a routine procedure that appears to offer a more stable experience for the mother without adding risk to the baby. While the researchers noted that their work was done at a single hospital and should be confirmed elsewhere, the findings offer a promising, practical way to make cesarean sections safer and more comfortable for the mothers undergoing them.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →